Harold J. Olney

1.4k total citations
41 papers, 516 citations indexed

About

Harold J. Olney is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Harold J. Olney has authored 41 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 18 papers in Genetics and 15 papers in Surgery. Recurrent topics in Harold J. Olney's work include Cancer, Hypoxia, and Metabolism (10 papers), Adrenal and Paraganglionic Tumors (10 papers) and Acute Myeloid Leukemia Research (8 papers). Harold J. Olney is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Adrenal and Paraganglionic Tumors (10 papers) and Acute Myeloid Leukemia Research (8 papers). Harold J. Olney collaborates with scholars based in Canada, United States and United Kingdom. Harold J. Olney's co-authors include Janet D. Rowley, Michelle M. Le Beau, Isabelle Bourdeau, Aaron R. Hansen, Kelly Brooks, Lisa Wang, Bertil Johansson, Krzysztof Mrózek, Soo Chin and Jennifer J. Knox and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Harold J. Olney

37 papers receiving 509 citations

Peers

Countries citing papers authored by Harold J. Olney

Since Specialization

Citations

This map shows the geographic impact of Harold J. Olney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold J. Olney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold J. Olney more than expected).

Fields of papers citing papers by Harold J. Olney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold J. Olney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold J. Olney. The network helps show where Harold J. Olney may publish in the future.

Co-authorship network of co-authors of Harold J. Olney

This figure shows the co-authorship network connecting the top 25 collaborators of Harold J. Olney. A scholar is included among the top collaborators of Harold J. Olney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold J. Olney. Harold J. Olney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Perioperative outcomes in patients with myeloproliferative neoplasms: a multicentric analysis of 354 surgical procedures 2024 ·PubMed ·Natasha Szuber, Harold J. Olney, Steve Dagenais-Bellefeuille, (unknown), (unknown), (unknown), (unknown), Jaroslav F. Prchal, Lambert Busque, Shireen Sirhan	1
2	Understanding the Lived Experience of Fatigue in Adolescents and Young Adults with Myeloproliferative Neoplasms: A Mixed Methods Study 2024 ·Blood ·Steve Dagenais-Bellefeuille, Karine Bilodeau, (unknown), Shireen Sirhan, Robert Delage, (unknown), (unknown), (unknown), Luigina Mollica, Danièle Marceau, (unknown), P. Desjardins, Harold J. Olney, (unknown), Lambert Busque, Natasha Szuber	0
3	12490 Management Of Autoimmune Hepatitis Under Mitotane Therapy: Reintroduction Of Mitotane Under High Dose Corticosteroids For Targeted Mitotane Therapeutic Levels In A Patient With Recurrent Myxoid Adrenocortical Carcinoma 2024 ·Journal of the Endocrine Society ·(unknown), Daphna Fenyves, Conrad Cloutier, Mathieu Latour, (unknown), Pierre I. Karakiewicz, Harold J. Olney, Isabelle Bourdeau	0
4	Central Hypothyroidism is Frequent During Mitotane Therapy in Adrenocortical Cancer Patients: Prevalence and Timeline 2023 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), (unknown), (unknown), Solange Grunenwald, Harold J. Olney, (unknown), André Lacroix, Philippe Caron, Isabelle Bourdeau	3
5	Perioperative Outcomes and Management in Patients with Myeloproliferative Neoplasms: A Multicentric Retrospective Analysis of 354 Surgical Interventions 2023 ·Blood ·Natasha Szuber, Steve Dagenais-Bellefeuille, (unknown), (unknown), (unknown), (unknown), Jaroslav F. Prchal, Harold J. Olney, Lambert Busque, Shireen Sirhan	1
6	Canadian real-world experience of asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy 2023 ·Leukemia Research ·(unknown), Sonia Cerquozzi, Harold J. Olney, (unknown), (unknown), Anargyros Xenocostas, (unknown), (unknown), Mary Lynn Savoie, Lambert Busque, Kareem Jamani, Philip Kuruvilla, (unknown), Brian Leber, Rayan Kaedbey, Sarit Assouline, Dennis Dong Hwan Kim	6
7	Adrenocortical cancer recurrence following initial transcutaneous biopsy: a rare demonstration of needle tract seeding 2021 ·SHILAP Revista de lepidopterología ·(unknown), Isabelle Bourdeau, Harold J. Olney, Paul Perrotte, (unknown), Mathieu Latour, David Roberge, André Lacroix	6
8	Small adrenal incidentaloma becoming an aggressive adrenocortical carcinoma in a patient carrying a germline APC variant 2020 ·Endocrine ·(unknown), (unknown), (unknown), (unknown), Irina Bancos, Mathieu Latour, Catherine Beauregard, (unknown), (unknown), Fred Saad, Harold J. Olney, Isabelle Bourdeau	3
9	Autologous Stem Cell Transplant for Treatment of Multiple Myeloma in a Patient with Concomitant Porphyria Cutanea Tarda 2020 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), (unknown), (unknown), (unknown), Harold J. Olney, Jean‐Philippe Adam	0
10	A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial 2019 ·British Journal of Cancer ·Grainne M. O’Kane, Shereen Ezzat, Anthony M. Joshua, Isabelle Bourdeau, Raya Leibowitz‐Amit, Harold J. Olney, Monika K. Krzyzanowska, (unknown), Soo Chin, Lisa Wang, Kelly Brooks, Aaron R. Hansen, L. Sylvia, Jennifer J. Knox	85
11	Rapid and Complete Remission of Metastatic Adrenocortical Carcinoma Persisting 10 Years After Treatment With Mitotane Monotherapy 2016 ·Medicine ·Nada El Ghorayeb, (unknown), Mathieu Latour, Christian Cohade, Harold J. Olney, André Lacroix, Paul Perrotte, (unknown), Tânia Longo Mazzuco, Isabelle Bourdeau	11
12	Laboratory Investigation of Myeloproliferative Neoplasms (MPNs) 2016 ·American Journal of Clinical Pathology ·Lambert Busque, Anna Porwit, (unknown), Harold J. Olney, Brian Leber, (unknown), Shireen Sirhan, (unknown), Jaroslav F. Prchal, Suzanne Kamel‐Reid, Aly Karsan, Vikas Gupta	24
13	Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12 2015 ·Blood ·John Kuruvilla, David MacDonald, C. Tom Kouroukis, Matthew C. Cheung, Harold J. Olney, A. Robert Turner, (unknown), Matthew D. Seftel, (unknown), Stefano Luminari, Stephen Couban, Tara Baetz, Ralph M. Meyer, Annette E. Hay, Lois E. Shepherd, Marina Djurfeldt, Syed Sameer Aga, Bingshu E. Chen, Michael Crump	28
14	Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group 2015 ·Clinical Lymphoma Myeloma & Leukemia ·Shireen Sirhan, Lambert Busque, Lynda Foltz, (unknown), Caroline Hamm, Nicole Laferriere, Pierre Laneuville, Brian Leber, (unknown), Harold J. Olney, Jaroslav F. Prchal, Anna Porwit, Vikas Gupta	8
15	Prolonged progression-free survival and preserved quality of life in the Canadian prospective study of tositumomab and iodine¹³¹-tositumomab for previously treated, rituximab-exposed, indolent non-Hodgkin lymphoma 2014 ·Leukemia & lymphoma ·Harold J. Olney, (unknown), Douglas A. Stewart, Joy Mangel, Darrell White, (unknown)	8
16	Vanishing Bile Duct Syndrome Arising in a Patient With T-Cell–Rich Large B-Cell Lymphoma 2013 ·Journal of Clinical Oncology ·(unknown), Bich Nguyen, Harold J. Olney, Bernard Lemieux	10
17	Prevalence of α-Globin Gene Deletions Among Patients with Unexplained Microcytosis in a North-American Population 2005 ·Hemoglobin ·Julie Bergeron, Xiaoduan Weng, (unknown), Harold J. Olney, Denis Soulières	11
18	Unique balanced chromosome abnormalities in treatment‐related myelodysplastic syndromes and acute myeloid leukemia: Report from an International Workshop† 2002 ·Genes Chromosomes and Cancer ·Harold J. Olney, Felix Mitelman, Bertil Johansson, Krzysztof Mrózek, Roland Berger, Janet D. Rowley	37
19	International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy‐related myelodysplastic syndromes and acute leukemia: Overview report 2002 ·Genes Chromosomes and Cancer ·Janet D. Rowley, Harold J. Olney	134
20	Rare recurring balanced chromosome abnormalities in therapy‐related myelodysplastic syndromes and acute leukemia: Report from an International Workshop† 2002 ·Genes Chromosomes and Cancer ·AnneMarie W. Block, Andrew J. Carroll, Anne Hagemeijer, (unknown), Kirsten van Lom, Harold J. Olney, Maria R. Baer	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact